FDA is warning consumers to not purchase or use Skin-Cap aerosol spray products because they may contain undisclosed steroids. This product, sold by Chemigroup France, formerly known as Cheminova Laboratories, has been found for sale on skincap.com, amazon.com, and walmart.com.
FDA testing identified a high-potency glucocorticosteroid (immunosuppressive and anti-inflammatory drugs) in Skin-Cap aerosol spray products that is not disclosed on the label or packaging.
Long-term use of topical corticosteroids, like glucocorticosteroids can cause health problems such as skin thinning (atrophy) and skin reactions, and if used on large body areas may lead to increased blood glucose (sugar) levels, changes in blood pressure, damage to bones, psychiatric problems, and changes in hormone levels (adrenal dysfunction).
FDA is not currently aware of any adverse events related to Skin-Cap aerosol spray products.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!